Please log in to save bookmarks. Only registered users can save their favorite pages.
Journal Properties
Number of Articles
748
Abbreviation
Hybridoma
ISSN
1554-0014
e-ISSN
1557-8348
Publisher
Mary Ann Liebert Inc
Indian UGC
DOAJ (latest)
Description
Hybridoma is a peer-reviewed journal dedicated to the study and application of hybridoma technology. The journal provides a comprehensive platform for researchers and practitioners to share their findings on the production, characterization, and utilization of monoclonal antibodies.
Key topics covered include: hybridoma cell line development, antibody engineering, antibody production at scale, and the use of monoclonal antibodies in diagnostics, therapeutics, and research. The journal also publishes studies on antibody-drug conjugates, bispecific antibodies, and other advanced antibody-based technologies. Hybridoma is indexed in major scientific databases and read by a global audience of immunologists, cell biologists, and biopharmaceutical researchers.
Hybridoma welcomes submissions that advance our understanding of antibody technology and its diverse applications. Contribute your research and help shape the future of antibody-based therapies and diagnostics. Relevant keywords include immunology, biotechnology, and proteomics.